Coe Management Group
Provider of workplace substance screening, compliance, and risk-management services for employers and individuals. Offers point-of-collection and laboratory drug testing across multiple specimen types, DOT program administration and reporting, background screening, DNA paternity testing, policy development for drug-free workplaces, and a national collection network.
Industries
Nr. of Employees
small (1-50)
Coe Management Group
Winston Salem, North Carolina, United States, North America
Products
5-Panel Drug Test
Instant test kit screening for five common drug classes; sold via the company product page.
16-Panel Drug Test
Instant test kit screening for an extended panel of up to 16 substances; sold via the company product page.
5-Panel Drug Test
Instant test kit screening for five common drug classes; sold via the company product page.
16-Panel Drug Test
Instant test kit screening for an extended panel of up to 16 substances; sold via the company product page.
Services
Employer-focused testing programs including pre-employment, random, post-accident, reasonable suspicion, DOT-regulated testing, instant screens, and laboratory confirmations.
End-to-end management of DOT testing programs including clearinghouse administration, required DOT reporting, certified collectors, and supervisor training.
Employment background checks and screening services to support hiring decisions and reduce organizational risk.
Creation and updating of drug-free workplace policies, workplace violence prevention programs, and related components (pre-employment, random, post-accident policies).
Facilitation of accredited laboratory paternity testing using oral swab collections for legal and personal purposes.
Retail offerings of instant/rapid drug test kits (e.g., 5‑panel, 16‑panel) and other testing devices for employer or individual use.
Employer-focused testing programs including pre-employment, random, post-accident, reasonable suspicion, DOT-regulated testing, instant screens, and laboratory confirmations.
End-to-end management of DOT testing programs including clearinghouse administration, required DOT reporting, certified collectors, and supervisor training.
Employment background checks and screening services to support hiring decisions and reduce organizational risk.
Creation and updating of drug-free workplace policies, workplace violence prevention programs, and related components (pre-employment, random, post-accident policies).
Facilitation of accredited laboratory paternity testing using oral swab collections for legal and personal purposes.
Retail offerings of instant/rapid drug test kits (e.g., 5‑panel, 16‑panel) and other testing devices for employer or individual use.
Expertise Areas
- Workplace drug and alcohol testing
- DOT compliance and program administration
- Employment background screening
- Forensic DNA paternity testing
Key Technologies
- Point-of-collection testing (POCT)
- Oral fluid (saliva) testing
- Hair follicle testing
- Urine drug testing
News & Updates
Summary and guidance regarding the DOT final rule enabling oral fluid testing for DOT-regulated employees; includes implementation considerations and HHS laboratory certification requirements.
Guidance on the implications of CBD product use for DOT-regulated employees, highlighting that CBD use does not exempt a positive marijuana result and noting labeling/quality concerns.
Overview of common prescription and illicit substances relevant to workplace testing and the role of medical review in verifying prescriptions.
Discussion of reasons to maintain current workplace drug testing policies, including protection, predictability, continuity, and adaptation to changes such as new OTC products and state marijuana laws.
Summary and guidance regarding the DOT final rule enabling oral fluid testing for DOT-regulated employees; includes implementation considerations and HHS laboratory certification requirements.
Guidance on the implications of CBD product use for DOT-regulated employees, highlighting that CBD use does not exempt a positive marijuana result and noting labeling/quality concerns.
Overview of common prescription and illicit substances relevant to workplace testing and the role of medical review in verifying prescriptions.
Discussion of reasons to maintain current workplace drug testing policies, including protection, predictability, continuity, and adaptation to changes such as new OTC products and state marijuana laws.